GlaxoSmithKline

  • Why are Drug Companies Nervous about OMSJ?

    OMSJ recently received this note from a criminal HIV defendant we are currently assisting:

    I talked with my attorney the other day and he told me that another outfit had contacted him about my case.  This outfit is called The Center for HIV Laws and Policy.  I didn’t contact them and wanted to advise you to see if you think they are on the up and up. (more…)

    Post to Twitter Tweet This Post

  • The Magic Effect

    Judy Balaban was the daughter of longtime Paramount Pictures president Barney Balaban. She didn’t know much about LSD when she started taking it, in the late 50s, but, she laughingly says, “I figured if it was good enough for Cary Grant, it was good enough for me!” (more…)

    Post to Twitter Tweet This Post

  • HAART Exposed: Sustiva Causes AIDS Symptoms

    2 Sept 2010 – Last year, OMSJ identified the HIV drug Sustiva (Efavirenz) as little more than a highly addictive anti-retroviral (ARV) placebo that, when interrupted, produces withdrawal symptoms that AIDS clinicians routinely use to misdiagnose the onset of AIDS. (more…)

    Post to Twitter Tweet This Post

  • NEMJ: Drugmakers Tamper with Trial Data

    30 Aug 2010An editorial in The New England Journal of Medicine, by its editor Jeffrey M. Drazen, M.D., and Alastair J.J. Wood, M.D. calls attention to the fact that pharmaceutical companies have tampered with the independent function of the Data Safety Monitoring Board (DSMB) and have planted promotional reports in The NEJM–and other (more…)

    Post to Twitter Tweet This Post

  • Another MD Busts AIDS Clerics

    Since 2006, Mexican cartels have killed 28,000 men, women and children in drug-related violence.  As troubling as these numbers are, those deaths and injuries represent a fraction of those who are negligently killed or injured by US doctors and drug companies every year.  Based upon admissions information, 3,607,000 patients suffered adverse drug reactions in 1994 alone.  (more…)

    Post to Twitter Tweet This Post

  • AHRP on Drug Trials & Guinea Pigs

    26 July:  Ana Cantu was a human guinea pig in a drug trial for $4,800:  “The study started out with 20 subjects… For about a week there were 14 subjects.  Then they started dropping… Now, we’re down to 7.” (more…)

    Post to Twitter Tweet This Post

  • Anatomy of a Drug Trial

    23 July – Exactly five years ago, in exchange for the most miserable month of my life, I got paid $4,800 to test the effects of a drug made by GlaxoSmithKline. (more…)

    Post to Twitter Tweet This Post

  • Glaxo Pays another $Billion for Paxil Lawsuits

    July 20  -  GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements. (more…)

    Post to Twitter Tweet This Post

  • Glaxo Settles Another Case for $460M

    13 July – GlaxoSmithKline Plc agreed to pay about $460 million to resolve a majority of lawsuits alleging the company’s Avandia diabetes drug can cause heart attacks and strokes, people familiar with the accords said (video). (more…)

    Post to Twitter Tweet This Post

  • Government Report Deals Blow to GlaxoSmithKline

    9 July – WASHINGTON — A federal drug official on Friday dealt a severe blow to the popular diabetes drug Avandia, issuing a scathing review of a major clinical trial that its manufacturer has been using to argue that the drug was safe.  The reviewer, Dr. Thomas Marciniak of the Food and Drug Administration, found a dozen instances in which patients taking (more…)

    Post to Twitter Tweet This Post

<<prev more>>

AT ISSUE

OMSJ Demands Editors to Depublish Gallo's Reports

TAKE ACTION

KEY ISSUES

    MORE